Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (271-280 of 286) with videos related to

Pageof 29
Sort By:
British Journal of Anaesthesia|August 10, 2020
Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importancePavel S Roshanov, John W Eikelboom, Daniel I Sessler, et al.
The New England Journal of Medicine|February 8, 2019
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Mark Crowther, John W Eikelboom, et al.
British Journal of Anaesthesia|July 29, 2020
Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort studyPavel S Roshanov, Gordon H Guyatt, Vikas Tandon, et al.
JAMA|October 12, 2023
Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical TrialDeborah M Siegal, Emilie P Belley-Côté, Shun Fu Lee, et al.
Arthritis Care & Research|August 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision AnalysisMedha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.
The Lancet. Haematology|November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
The Lancet. Haematology|September 25, 2020
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysisHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Pageof 29

Showing results (271-280 of 286) with videos related to

Sort By:
Pageof 29
British Journal of Anaesthesia|August 10, 2020
Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort study establishing diagnostic criteria and prognostic importancePavel S Roshanov, John W Eikelboom, Daniel I Sessler, et al.
The New England Journal of Medicine|February 8, 2019
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Mark Crowther, John W Eikelboom, et al.
British Journal of Anaesthesia|July 29, 2020
Preoperative prediction of Bleeding Independently associated with Mortality after noncardiac Surgery (BIMS): an international prospective cohort studyPavel S Roshanov, Gordon H Guyatt, Vikas Tandon, et al.
JAMA|October 12, 2023
Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical TrialDeborah M Siegal, Emilie P Belley-Côté, Shun Fu Lee, et al.
Arthritis Care & Research|August 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision AnalysisMedha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
BMJ Open|May 1, 2016
Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocolHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.
The Lancet. Haematology|November 9, 2019
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trialChristoph Male, Anthonie W A Lensing, Joseph S Palumbo, et al.
The New England Journal of Medicine|May 15, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral HemorrhageStuart J Connolly, Mukul Sharma, Alexander T Cohen, et al.
The Lancet. Haematology|September 25, 2020
Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysisHolger J Schünemann, Matthew Ventresca, Mark Crowther, et al.
Pageof 29